The pharmaceutical industry is under growing scrutiny from regulators when it comes to CAPA effectiveness checks. This blog explores how to improve root cause analysis, ensure closed-loop CAPA systems, and avoid repeat findings in GMP audits.
Effective CAPA is key to medical device quality, but meeting FDA's CFR Part 820 QSR requirements is just the first step. Pitfalls like shallow investigations and reactive approaches can still land you in hot water. Zamann Pharma Support helps you
